Cepheid Provides Q2 Outlook

(RTTNews) - Cepheid (CPHD) Thursday issued an outlook for the second quarter of 2013.

For the second quarter, the company expects GAAP loss of about $6.6 million, or $0.10 per share, adjusted net income of $1.2 million, or $0.02 per share and revenue of about $96 million.

Analysts polled by Thomson Reuters currently estimate loss of $0.03 per share and revenues of $92.20 million for the quarter. Analysts' estimates typically exclude few items.

The second-quarter revenue includes, about $70 million in commercial clinical revenue, $17 million from HBDC, and $9 million in non-clinical revenue.

Chief Executive John Bishop said, "Revenue was driven by strength in HBDC and solid growth in our international commercial clinical business. Second quarter commercial clinical revenue in North America was at the lower end of our target range, although improving customer confidence allowed our sales organization to return to higher levels of productivity late in the quarter."~